Through its robust IoT enterprise monitoring platform and licensing, subscription recurring revenue business model, GTX Corp. offers a complete end-to-end solution backed by an extensive portfolio of patents with filing dates going back as early as 2002, patents pending, registered trademarks, copy rights and URLs. GTX was featured in a 38-page research piece outlining the value proposition of the company’s IP portfolio, and was also published in a SeeThruEquity research report discussing the value of the company’s IP.

GTX has established a growing global distribution network with partners in more than 20 countries, and has garnered millions of dollars’ worth of free media with coverage on CNN, Good Morning America, The Doctors, Fox News, Discovery Channel, ABC, NBC, CBS, The New York Times, LA Times, U.S.A. Today, the LA Business Journal, AARP and hundreds of other television, radio, magazine and newspaper media outlets across the globe.

The company’s flagship, patented GPS SmartSoles were recently showcased in Munich at the Telefonica Digital Innovation Day 2015; was featured in AARP’s 2015 technology gear guide; and came in second place, with Microsoft finishing first and Samsung taking third, in the 2015 Wearables, Health, Fitness & Wellness category at CTIA’s Hot for the Holidays Awards competition.

As GTX continues to expand its brand awareness and distribution channels both domestically and internationally, in parallel it also plans to introduce new products with an emphasis on e-health and wellness. Corporate strategies are guided by a visionary management team with the insight and experience needed to navigate the plentiful opportunities and potential market share in the emerging multibillion IoT and Wearable Tech industries.

“With approximately 2% of the population having been diagnosed with Alzheimer’s, dementia, autism, TBI or some other cognitive disorder which may lead to wandering due to memory loss, GTX plays a vital role in the safety, security and recovery of these individuals and their caregivers.” — Patrick Bertagna GTX Corp CEO.

For more information, visit www.gtxcorp.com

Let us hear your thoughts: GTX Corp. Message Board

The reinvigoration of the U.S. manufacturing sector is bolstering the economy and creating thousands of stable jobs. For the first time in more than a decade, domestic output and employment figures are recording steady growth, with manufacturing output increasing by 38 percent since the end of the recession, according to the U.S. Department of Commerce. This shift toward domestic manufacturing solutions has accounted for 19 percent of the rise in real gross domestic product since June 2009, as well as adding 646,000 jobs, as of June 2014.

The state of Florida, in particular, has benefitted from this manufacturing boom. Florida currently has approximately 321,000 manufacturing employees in various industries, and Oakridge Global Energy Solutions, Inc. is doing its part to sustain this economic growth. As part of its recent expansion, the company created more than 1,000 new jobs in Palm Bay, Florida, through the launch of its new 68,700 square foot manufacturing facility.

Earlier this month, Florida Governor Rick Scott, along with several local dignitaries and business entrepreneurs, met with members of the Oakridge staff and executive team to celebrate the company’s positive impact on the local community.

“Oakridge Global Energy Solutions could have moved their headquarters anywhere in the world, and I am proud to announce that they chose to remain in Florida and create 1,000 new jobs,” Governor Scott told the media following a tour of the company’s new facility. “Growing businesses like Oakridge… create opportunities for Floridians to provide for their families and build great careers.”

In recognition of the company’s impact on the local economy, the governor bestowed the prestigious ‘Governor’s Business Ambassador’ medal to Oakridge executive chairman and CEO Steve Barber.

Oakridge has made considerable progress toward capitalizing on its current momentum in recent weeks. The company recently announced that it has completed testing on both its ProSeries line of heavy duty battery systems for task oriented vehicles and its Patriot Series line of battery systems for radio controlled vehicles. Both lines utilize Oakridge’s proprietary chemistry formulation, allowing users to operate their vehicles much longer than is possible using conventional batteries. Moving forward, both product lines will be manufactured at the company’s expanded plant in Florida.

For prospective shareholders, Oakridge represents an opportunity to invest in both a rapidly growing company and a key player in the ongoing effort to bring jobs back to American soil.

For more information, visit www.oakg.net

Avant Diagnostics, a medical technology company focused on bringing to market cutting-edge diagnostic tests based upon the completion of the human genome sequencing project, has developed a sophisticated and much-needed screening test for diagnosing ovarian cancer. OvaDx is the market’s first large-panel biomarker screening test for ovarian cancer.

Discoveries in genetic research offer far-reaching opportunities for impacting both the diagnosis and treatment of serious disease. It centers on identifying variations in specific genes in the genome, variations that define individual characteristics, including disease states or a statistical propensity for disease. Diagnostic tests that detect diseases early in their progression will provide options for earlier treatments to improve the quality of life and outcome by delaying or preventing disease progression or even death. Medical providers will enjoy major cost savings by avoiding costly late stage disease treatments.

The American Cancer Society estimated diagnosis in 2013 of about 22,240 new cases of ovarian cancer, with perhaps 15,500 ovarian cancer deaths in the U.S., making ovarian cancer the fifth leading cause of cancer death among U.S. women. Other cancers have shown a marked reduction in mortality due to the availability of early detection tests and improved treatment, but this has not been the case with ovarian cancer, which has been called “the silent killer”. Early stage disease symptoms are often ignored, and current tests can lead to false diagnosis and unnecessary treatment. One study found that, on average, for every one case of ovarian cancer detected, 33 women had surgery for a false positive.

The Avant Diagnostics approach is based upon 10 years of genetic and physiological research, focused on exploiting the human immune system for early detection. The result, OvaDx, offers a large panel of refined markers for high sensitivity. OvaDx markers and kits are proprietary, with a patented manufacturing technology, and a worldwide exclusive license, and the company is progressing toward FDA 510(k) clearance for OvaDx.

For more information on the company, visit www.avantdiagnostics.com

Let us hear your thoughts: Avant Diagnostics, Inc. Message Board

Legacy Ventures International is designed around the acquisition of proven and high-potential businesses across a variety of business sectors. Legacy is set up to provide critical capital and oversight to companies offering innovative products that are considered category game-changers, and established brands that are considered fast growth. Legacy looks for companies with big ideas that are able to scale hyper-growth, and recently acquired RM Fresh Brands representing an extensive portfolio of highly desirable food and beverage brands.

With a focus on young companies offering fast growth potential, companies that need managerial and financial support, Legacy’s executive team is built around strong entrepreneurial and financial expertise.

• Evan Clifford (CEO) – Having extensive experience in both private and public sector entrepreneurial startups, Mr. Clifford has developed key relationships throughout many different industries, and has established a reputation for successfully building and promoting companies as well as the individual careers of top performing artists. He has been a speaker at the world-renowned Idea City Conference and has coached selected companies and individuals to achieve personal and professional success.

• Rehan Saeed (CFO, Director, Chairman) – With a degree in Information Technology, as well as an MBA and CPA, Mr. Saeed has established himself across multiple verticals in the banking industry, and has served in both CFO and vice presidential roles. In only two years, he built and managed a $110 million real estate portfolio. As VP of AYA Financial, Mr. Saeed brought in over $30 million in revenue, and increased profitability by 25% above the competition. Mr. Saeed also teaches college-level investments & finance, and consults law firms on financing.

• Matt Merson (Board of Directors) – Mr. Merson is a senior sales and marketing executive, with over 25 years in the branded food and beverage space, including such major organizations as Coca-Cola, Dannon Yogurt, and Sara Lee. He has specialized in the startup space for emerging brands that are disrupting the norm or creating entirely new categories. Mr. Merson thrives on building teams that can create strategic plans and objectives to bring brands to life across all channels of sales. He has expertise in all functional areas including operations, finance, marketing, human resources, and international sales.

For further information on Legacy Ventures or RM Fresh Brands, visit www.LegacyVenturesInc.com and www.RMFreshBrands.com

Let us hear your thoughts: Legacy Ventures International, Inc. Message Board

Giggles N’ Hugs is a first-to-market, award-winning family restaurant and play space that brings organic gourmet food together with a play environment for children in a 2500-square-foot play space in the middle of the restaurant.

The company was launched in 2010 courtesy of Dorsa and Joey Parsi’s vision when they could not find anywhere to go and have a meal that catered to the needs of their daughter. It was at that point the couple began to explore the question pertaining to why the market was void of a solution.

The Parsi’s soon recognized that all of the “kid friendly” restaurants did a pretty good job of catering to adults but strikingly seemed to miss the bigger target – the smaller customer. Everything from furniture to eating utensils seemed to address the needs of mom and dad but nothing about these environments was appealing to their children. As a mom, Mrs. Parsi was always thinking of ways to make life more fun for her daughter while making it a little easier for her and her husband.

The Parsi’s question beckoned, ‘how can there not be a single restaurant just for kids, yet also parent friendly?’ Why not develop a restaurant concept where parents can enjoy a healthy, delicious meal and the kids can act their age? As the Parsi’s question began to take shape, the couple pursued the answer to the question as to why they couldn’t go out to dinner somewhere where they didn’t have to keep telling their daughter to sit down and be quiet. And as with so many successful business ventures, their idea took shape out of market need.

Giggles N’ Hugs, Inc. now owns and operates kid-friendly restaurants with play areas for children under 10 years of age in California. The company owns and operates a restaurant in the Westfield Mall in Century City, a restaurant in the Westfield Topanga shopping center in Woodland Hills, and a restaurant in the Glendale Galleria in Glendale, California.

For more information on the company, visit www.gigglesnhugs.com

Let us hear your thoughts: Giggles ‘N Hugs, Inc. Message Board

Cherubim Interests, Inc. has announced a plan its already begun executing to acquire income-producing properties through the creation of a class of Convertible Preferred Stock.

“Cherubim Interests, Inc. will begin placing an issue of convertible preferred shares to fund the acquisition of one or more income producing properties,” stated Patrick J. Johnson, CEO of CHIT. “The properties will in turn generate revenue for the Company and holders of the preferred stock.”

According to the press release, income from the investment properties will be tied to the preferred stock and paid out as dividends. The price for each share of the preferred stock has been set at $5.00 (US). The location for the first group of properties will be released in the coming weeks as negotiations continue to move forward.

“We are looking at a variety of locales and situations that have strong investment potential,” added Johnson. “We’ve narrowed the field and are closing in on our first targets. We expect things to happen very quickly. Look for more information in the coming weeks as a deal could be done as early as the end of this month.”

Cherubim Interests believes that creating a portfolio of income-producing properties will be an important part in its current strategy of acquiring assets and building wealth for shareholders.

For more information on the company, visit www.cherubiminterests.com

Let us hear your thoughts: Cherubim Interests, Inc. Message Board

Following the recently announced completion of a design study for its proprietary RUBICON™ solid oxide fuel cell (SOFC) system, Dominovas Energy Corporation (OTCQB: DNRG) is now entering the next level of detailed design, engineering and manufacturing of its multi-megawatt systems in order to realize the promise of supplying sustainable power generation capacity to sub-Saharan Africa. Last week, the company secured $1.2 billion of project financing from Graecrest Energy Solutions, effectively setting the stage for the anticipated commercial deployment of its innovative technology in both the Democratic Republic of the Congo (DRC) and the surrounding region.

“This is an unprecedented and historic commitment not only for Dominovas Energy, but it is additionally significant for the fuel cell industry as a whole,” Neal Allen, chairman and chief executive officer of Dominovas Energy, stated in a news release. “This financing commitment is further validation of the company’s business model and an undeniable endorsement of the technical prowess of the RUBICON™ and the ‘game plan’ we have set forth for the commercial deployment of our fuel cell system.”

The DRC, in particular, represents an immense opportunity for Dominovas Energy to establish a foothold in the emerging energy markets of sub-Saharan Africa. Since the beginning of the year, the company has signed and executed over 200MW of guaranteed power purchase agreements (PPAs) within the nation. In total, that’s enough electricity to adequately power over 200,000 homes, but these agreements could be the tip of the iceberg. Through the U.S. government’s Power Africa Initiative (PAI), Dominovas Energy will look to help generate roughly 30,000MW of new and cleaner power in the region over the coming years.

A report by research firm McKinsey & Company highlighted the immense potential of the electricity sector of sub-Saharan Africa. Currently, nearly 600 million people throughout the region live without electricity, and seven countries report electrification of 50 percent or less. However, by 2040, the region is expected to see a fourfold increase in total demand, with more than 25 percent of all electricity coming from environmentally-friendly sources, such as the RUBICON™.

As the only fuel cell company selected as a private sector partner to the PAI, Dominovas Energy is in a strong position to provide a viable solution to the sub-Saharan region’s mounting energy sector concerns. With financing in place for the first stage of its manufacturing and installation operations and its initial design study now complete, the company appears to be primed to capitalize on the marketability of its proprietary SOFC technology moving forward.

For more information, visit www.dominovasenergy.com

Let us hear your thoughts: Dominovas Energy Corp. Message Boards

In an exclusive interview with QualityStocks, Alternet Systems, Inc. chairman and chief executive officer Henryk Dabrowski outlined the company’s promising future in several multi-billion dollar markets. Big data, in particular, was highlighted as an area of immense potential. In 2016, the company plans to launch a full suite of innovative solutions targeting the lucrative data analytics markets of the U.S. and Latin America, giving it a sustainable foothold in one of the world’s most rapidly expanding industries.

According to the International Data Corporation, the big data technology and services market is expected to grow at a compound annual growth rate of 26.4 percent through 2018 – roughly six times the pace of the overall information technology industry. As a result, the market is expected to climb to a value of $41.5 billion over the next three years. While well-known players such as SAP (NYSE: SAP) and Oracle (NASDAQ: ORCL) have established a presence in the big data space, the early success of startups like Splunk, Inc. (NASDAQ: SPLK) demonstrate the approachable barrier of entry for firms with innovative solutions that address specific market needs.

When defining Alternet’s four-year plan, Dabrowski went beyond the big data space to illustrate the company’s potential in a collection of thriving markets. In recent months, Alternet has leaned on the tremendous experience of its management team as it has repositioned itself to capitalize on these opportunities. In 2014, the company announced the sale of its majority-owned subsidiary Utibas Americas, and that announcement has served as a catalyst for a reinvention of its business model.

The company’s recent transformation from previous technologies into both the data analytics and payment processing industries is expected to spur the establishment of new lines of business for the foreseeable future. Dabrowski echoed this potential during the interview with QualityStocks.

“We feel that this turn has provided our company with a renewed vision and objective that will propel us into a potential half a billion dollar market within the next four years,” Dabrowski stated. “Alternet in 2016 will effectively have launched two lines of business, which are solutions for the payment processing industry. We will also have launched our suite of solutions for the data analytics space where we will be targeting markets in the U.S. and Latin America.”

With a clear plan to establish a presence in a collection of viable, high-growth markets, Alternet is primed to realize tremendous growth in the years to come. Look for the company to benefit from the multi-decade experience of its management team as it continues to execute on its four-year plan moving forward.

For more information, visit www.alternetsystems.com

Let us hear your thoughts: Alternet Systems, Inc. Message Board

GPS-enabled technologies provide a host of benefits to both businesses and consumers. According to a study by Motorola (NYSE: MSI), businesses that implement GPS fleet tracking technologies report yearly fuel savings of more than $51,500. As a result, market demand for innovative GPS tracking devices has been on the rise in recent years. Location Based Technologies, Inc. (OTC PINK: LBAS) is addressing this demand by designing and manufacturing tracking devices to better manage people, vehicles and assets. The company’s product line includes an innovative selection of personnel tracking, vehicle tracking and asset tracking solutions.

LBAS currently markets its products under the PocketFinder and LBT brands. Through PocketFinder, the company markets a selection of consumer products specially designed to track and locate mobile assets, people, pets or other valuable items. Through LBT, LBAS markets tracking products targeted at commercial applications. The LBT Vehicle Tracker, for example, combines reliable tracking features with a host of additional capabilities – including temperature measurement, light and humidity monitoring, engine monitoring and starter interrupt engine capabilities – designed to improve the safety and cost-effectiveness of fleet operations.

In 2014, LBAS achieved several key milestones that demonstrated the viability of its business model. In addition to recording positive overall gross margins for the first time in its history, the company’s monthly service income exceeded $100,000 per month beginning in July 2014. This financial growth was a result of an increase in total paid monthly users, which exceeded 72,000 last year.

Throughout 2015, LBAS has turned its attention toward cutting costs and expanding its distribution capabilities. The company previously partnered with a world-class distributor and expanded relationships with key strategic retail outlets in Mexico in pursuit of this goal. Additionally, LBAS outlined a major initiative focused on partnering with auto dealerships in the U.S. that’s expected to provide a boost to financial results.

In its most recent quarterly report, LBAS identified the introduction of a new 3G wearable device and a more complete solution for the pet markets as key initiatives moving forward. As the company continues to focus on research and development efforts, rising demand for location-based products should support an opportunity for financial growth in the future.

For more information, visit www.pocketfinder.com or www.locationbasedtech.com

OncoVista Innovative Therapies is a San Antonio, Texas-based drug development company employing a blend of innovative drug discovery, registration strategies and emerging technologies in order to bring to market less toxic and highly effective anti-cancer drugs.

As part of this model, the company focuses on acquisition candidates previously tested in human clinical trials or animal models, as well as technologies with potential to improve the delivery or targeting of previously tested, and in some cases marketed, anti-cancer agents.

From here, OncoVista intends to develop the candidates into novel, highly efficacious therapies to be marketed and commercialized via corporate partnerships with industry leaders, generating revenues through licensing/milestone fees and royalties flowing from out-licensing/partner agreements.

OncoVista’s current focus is on advancing its oncology drug candidate pipeline, which includes Cordycepin (OVI-123), in phase I/II clinical trials for the treatment of Refractory TdT Positive Leukemias; and L-Nucleoside Conjugates (OVI-117), under clinical development for the treatment of colon cancer.

After dealing with capital snags in 2008, which resulted in halting clinical trials of Cordycepin in 2009, recent corporate announcements signal that OncoVista is getting back on course. The company earlier this month announced two sources of bridge financing (Chicago Venture Partners of Chicago and a high net worth individual), expected to accelerate the process of getting the company operational again. With step one of the financing process underway, OncoVista is now working on a larger equity deal (step two) for the funding of both trials.

Initiatives are headed by CEO Dr. Alexander L. Weis, who has more than 20 years in the biopharmaceutical industry and more than 60 publications and 28 patents. Dr. Weis is supported by an experienced board of directors, as well as a clinical advisory board comprised of members with key roles in the development of a variety of oncology/chemotherapy drugs, including Taxol®, Hycamtin®, Eloxatin™, Taxotere®, Camptosar®, Taxotere®, Campath® and Tarceva®.

With a bit of wind back in its sails, OncoVista is actively pursuing the advancement of its oncology drug candidate pipeline for the treatment of leukemia and colon cancer.

For more information visit www.oncovista.com